Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

https://doi.org/10.1016/0002-9343(89)90335-5Get rights and content

Abstract

purpose and patients and methods: Antiphospholipid antibodies, lupus anticoagulant antibodies to cardiolipin, and a false-positive result on testing for syphilis have been linked to thrombotic vascular occlusions, particularly in patients with systemic lupus erythematosus (SLE) or lupus-like disease, i.e., patients not fulfilling four American Rheumatism Association criteria for the classification of SLE. The clinical and serologic features of 35 patients with cerebrovascular disease (strokes/transient ischemic attacks) who demonstrated antibodies to phospholipids are presented. Complete histories were obtained from all 35 patients, and all underwent routine physical examinations, radiography, electrocardiography, computed tomographic brain scanning, and immunologic studies. Psychometric tests were performed in nine patients.

results: The strokes were often multiple and were followed by multi-infarct dementia in nine patients. Of particular interest were 10 patients in whom the presence of antiphospholipid antibodies was the major and often the sole immunologic disturbance present. Several of these patients were antinuclear antibody-negative, and the antinuclear antibodies, when present, were usually of a low titer (1:40 to 1:160). These patients conform to a group classified as having a primary antiphospholipid syndrome.

conclusion: Antiphospholipid antibodies are strongly associated with cerebrovascular occlusions in patients with SLE as well as in those with lupus-like disease and the primary antiphospholipid syndrome. All patients with any of these conditions who present with vascular events should be screened for these antibodies, as their occurrence may have a bearing on future therapy.

References (69)

  • MA Khamashta et al.

    Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies

    Ann Rheum Dis

    (1988)
  • RA Asherson et al.

    Recurrent stroke, multi-infarct dementia in systemic lupus erythematosus associated with antiphospholipid antibodies

    Ann Rheum Dis

    (1987)
  • BM Coull et al.

    Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies

    Stroke

    (1987)
  • SR Levine et al.

    The spectrum of neurologic disease: association with anti-phospholipid antibodies

    Arch Neurol

    (1987)
  • AE Gharavi et al.

    Anticardiolipin antibodies: isotype distribution and phospholipid specificity

    Ann Rheum Dis

    (1987)
  • EN Harris et al.

    Evaluation of the anticardiolipin antibody test: report of an international workshop held 4th April 1986

    Clin Exp Immunol

    (1987)
  • EM Tan et al.

    The 1982 revised criteria for the classification of SLE

    Arthritis Rheum

    (1982)
  • RT Johnson et al.

    The neurological manifestations of systemic lupus erythematosus: a clinical pathological study of 24 cases and a review of the literature

    Medicine (Baltimore)

    (1968)
  • RS Boyer et al.

    Immunoperoxidase staining of the choroid plexus in systemic lupus erythematosus

    J Rheumatol

    (1980)
  • C Atkins et al.

    The choroid plexus in systemic lupus erythematosus

    Ann Intern Med

    (1972)
  • HG Bluestein et al.

    Brain reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus

    J Clin Invest

    (1976)
  • B Bresnihan et al.

    An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus

    Arthritis Rheum

    (1979)
  • EC Clark et al.

    Nervous system findings associated with systemic lupus erythematosus

    Minn Med

    (1956)
  • A Silverstein

    Cerebrovascular accidents as the initial major manifestation of lupus erythematosus

    NY State J Med

    (1963)
  • R Bennett et al.

    Neuropsychiatric problems in systemic lupus erythematosus

    Br Med J

    (1972)
  • JR Mueh et al.

    Thrombosis in patients with the “lupus anticoagulant.”

    Ann Intern Med

    (1980)
  • CC Waddell et al.

    The lupus anticoagulant in 14 male patients

    JAMA

    (1982)
  • G Landi et al.

    Recurrent ischemic attack in two young adults with lupus anticoagulants

    Stroke

    (1983)
  • D Anderson et al.

    Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies

    J Rheumatol

    (1987)
  • RG Hart et al.

    Cerebral infarction associated with lupus anticoagulants—preliminary report

    Stroke

    (1984)
  • RE Kelly et al.

    Cerebral ischemia in the presence of lupus anticoagulant

    Arch Neurol

    (1984)
  • JG D'Alton et al.

    Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis

    Stroke

    (1985)
  • M Elias et al.

    Thromboembolism in patients with the “lupus-type” circulating anticoagulant

    Arch Intern Med

    (1985)
  • AK Dosekun et al.

    Ancrod in systemic lupus erythematosus with thrombosis: clinical and fibrinolysis effects

    Arch Intern Med

    (1984)
  • Cited by (328)

    • Clinical presentation of antiphospholipid syndrome

      2021, Lahita’s Systemic Lupus Erythematosus
    • Bilateral central retinal artery occlusion in a patient with systemic lupus erythematosus

      2015, Journal of Stroke and Cerebrovascular Diseases
      Citation Excerpt :

      Stroke is prevalent in 2%-15% SLE patients.8 The presence of lupus anticoagulant and anticardiolipin antibodies in SLE patient is associated with a higher risk of developing severe vaso-occlusive retinopathy2,9 and ischemic infarction.10 Nevertheless, in one study, the prevalence of lupus anticoagulant and anticardiolipin antibodies was similar in SLE patients with ischemic infarction, and the most common type of ischemic infarction was small-vessel disease among SLE patients.11

    • The risk of ischemic stroke in major rheumatic disorders

      2014, Journal of Neuroimmunology
      Citation Excerpt :

      This finding highlights hypertension as a potent IS risk factor in SLE, although management of coexisting conventional risk factors may differ in scope from one geographic region to another. The presence of APA in SLE is strongly associated with IS (Asherson et al., 1989). An analysis of 29 published series (covering over 1000 patients with SLE) yielded an average prevalence of 34% for lupus anticoagulant (LAC) and 44% for anticardiolipin antibodies (ACL) (Love and Santoro, 1990).

    • Endosomal vesicles as vehicles for viral genomes

      2014, Trends in Cell Biology
      Citation Excerpt :

      Autoantibodies against BMP result in autoimmune disorders such as antiphospholipid syndrome and Niemann–Pick type C syndrome. Anti-BMP antibodies cause dysfunctional sorting and trafficking in LEs [20,21], suggesting a critical role for BMP in LE function and dynamics. Recent evidence suggests that these changing lipid compositions in endosomes, combined with the pH threshold of fusion, may direct virus entry to specific points along the endocytic pathway.

    • Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: A controlled study

      2011, Thrombosis Research
      Citation Excerpt :

      It is worth pointing out that 21 out of 34 (61.7%) patients had an abnormal pathologic value to at least one of the used specific tests for the determination of the APA. An association between ischemic stroke and the presence of APA has been reported in retrospective [9,10] and in prospective controlled studies [11–14]. Patients with ischemic stroke and APA are younger than the general stroke population, even if this association in older patients has been recently reported [10,13,14].

    View all citing articles on Scopus

    This work was supported by the British SLE Aids Group, Jean Sahankz Foundation, and the Caja be Madrid.

    View full text